Pelaksanaan Perjanjian Dana Pensiun Lembaga Keuangan Berdasarkan Undang-undang Nomor 11 Tahun 1992 Tentang Dana Pensiun

PT. Bank Negara Indonesia (Persero) Tbk. One is the founder and Pension Fund. The problems discussed in this research is how the implementation of the agreement, PT Pension Fund. Bank Negara Indonesia (Persero) in the main branches of Surakarta and legal consequences in case of breach of contract committed by one of the parties in the implementation of the agreement, PT Pension Fund. Bank Negara Indonesia (Persero) Tbk. The goal is to determine the implementation of the agreement, PT Pension Fund. Bank Negara Indonesia (Persero) Tbk in the main branches of Surakarta and legal consequences in case of breach of contract committed by one of the parties in the implementation of the agreement, PT Pension Fund. Bank Negara Indonesia (Persero).mplementation of the agreement, PT Pension Fund. Bank Negara Indonesia (Persero) started since reaching an agreement between the parties known of the existence of participant\u27s signature on the membership application form and ending at the time of payment of pension benefits, either died or moved to another Pension Fund. In the event of default of the parties, the legal consequences for the Pension Fund is responsible for the harm done, whereas for participants who violate the agreement in the agreement then the agreement is declared null and void. In addition to the settlement of defaults can be settled amicably or through the Indonesian National Board of Arbitration (BANI)

Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults

Abstract Background By assessing the changes in concentration of soluble receptor activator of nuclear factor κ B ligand (RANKL) and osteoprotegrin (OPG) after initiation of combination antiretroviral therapy (cART) in treatment-naïve HIV-infected patients we aimed to evaluate whether the initial accelerated bone loss could be mediated by increased soluble RANKL (sRANKL) levels associated with CD4+ T cell recovery. Methods We used multiplex immunoassays to determine sRANKL and OPG concentrations in plasma from 48 HIV patients at baseline and 12, 24, 48 and 96 weeks after cART initiation. Results Soluble RANKL changed significantly over time (overall p = 0.02) with 25% decrease (95% CI: -42 to −5) at week 24 compared to baseline and stabilized at a lower level thereafter. We found no correlation between CD4+ T cell count increment and changes in sRANKL or between percentage change in BMD and changes in sRANKL. Conclusion In this study there was no indication that the accelerated bone loss after cART initiation was mediated by early changes in sRANKL due to CD4+ T cell recovery. Future studies should focus on the initial weeks after initiation of cART. Trial registration Clinical-Trial.gov . id NCT00135460 , August 25, 2005. The study was approved by the Danish Data Protection Agency, Danish Medicines Agency and Regional Ethics Committee